The Federal Motor Carrier Safety Administration's National Registry of Certified Medical Examiners and Medical Certification of Interstate Commercial Motor Vehicle Drivers

2013 ◽  
Vol 61 (11) ◽  
pp. 503-503
Keyword(s):  
Motor Vehicle ◽  
National Registry ◽  
Motor Carrier ◽  
Medical Certification ◽  
Commercial Motor Vehicle ◽  
Commercial Motor Vehicle Drivers ◽  
Medical Examiners

Methodology for Estimating Vehicle Miles Traveled for Commercial Motor Vehicles at the State Level

2003 ◽  
Vol 1830 (1) ◽  
pp. 72-76
Author(s):  
Candace Brown ◽  
Nancy Kennedy ◽  
Don Wright ◽  
Walt Zak
Keyword(s):  
Program Effectiveness ◽  
Motor Vehicle ◽  
State Level ◽  
The State ◽  
Motor Vehicles ◽  
Commercial Vehicles ◽  
Motor Carrier ◽  
Exposure Data ◽  
Commercial Motor Vehicle ◽  
Commercial Motor Vehicles

Described is one specific effort to better estimate commercial motor vehicle-related exposure at the state level in order to better determine commercial motor vehicle-related crash rates for state and federal programs. Limitations in the crash and exposure data affect the Federal Motor Carrier Safety Administration and a state’s ability to plan and assess operations and conduct ongoing analyses of program effectiveness. One important limitation has been the lack of reliable estimates of commercial motor vehicle exposure data at the state level. Exposure data, for the purpose of this report, are defined as the number of truck and bus vehicle miles traveled (VMT). Described is the methodology that was developed to calculate adjusted state VMT for commercial vehicles; results are presented for 1999 and 2000. The results support estimation of crash involvement rates for each state and provide exposure data for other analytical studies. The methodology to calculate adjusted state VMT for commercial motor vehicles has resulted in improved information resources in support of all crash analyses. The adjusted state VMT for commercial vehicles supports measurement of program effectiveness and development of countermeasures to promote motor carrier safety. The adjusted state VMT for commercial motor vehicles methodology and the commercial vehicle fatal-crash involvement rate reports enable state and federal agencies to better focus their safety programs and enforcement resources.

High risk of obstructive sleep apnea, insomnia, and daytime sleepiness among commercial motor vehicle drivers

2019 ◽  
Vol 23 (3) ◽  
pp. 979-985 ◽  
Author(s):  
Jun-Sang Sunwoo ◽  
Dae-Seop Shin ◽  
Young Hwangbo ◽  
Won-Joo Kim ◽  
Min Kyung Chu ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
High Risk ◽  
Daytime Sleepiness ◽  
Motor Vehicle ◽  
Obstructive Sleep ◽  
Commercial Motor Vehicle ◽  
Commercial Motor Vehicle Drivers

scholarly journals Portable Diagnostic Devices and Commercial Motor Vehicle Drivers

SLEEP ◽  
2013 ◽  
Vol 36 (8) ◽  
pp. 1263-1264
Author(s):  
Chunbai Zhang ◽  
Mark Berger ◽  
Atul Malhotra ◽  
Stefanos Kales
Keyword(s):  
Motor Vehicle ◽  
Commercial Motor Vehicle ◽  
Commercial Motor Vehicle Drivers

Coronary Artery Disease Evaluation and Management Considerations for High Risk Occupations: Commercial Vehicle Drivers and Pilots

2021 ◽  
Author(s):  
Nadia R. Sutton ◽  
Shrilla Banerjee ◽  
Matthew M. Cooper ◽  
Armin Arbab-Zadeh ◽  
Judy Kim ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Heart Disease ◽  
High Risk ◽  
Motor Vehicle ◽  
Commercial Vehicle ◽  
Current Guideline ◽  
Transportation Industry ◽  
Artery Disease ◽  
Commercial Motor Vehicle Drivers ◽  
Medical Examiners

Optimal treatment of stable ischemic heart disease for those in the transportation industry is considered in the context of the individual’s health, as well as with the perspective that sudden impairment could have catastrophic consequences for others. This article focuses on two high risk occupations that one may encounter in practice: commercial motor vehicle drivers and commercial pilots. This article discusses coronary heart disease in patients in high risk occupations and covers current guideline recommendations for screening, treatment, and secondary prevention. The importance of the complimentary perspectives of the regulatory agency, medical examiners, physicians, and pilot or driver are considered in this narrative review, as are considerations for future guideline updates.

Sign in / Sign up

Export Citation Format

Share Document